Understanding Sources of Variation to Improve the Reproducibility of Radiomics

Radiomics is the method of choice for investigating the association between cancer imaging phenotype, cancer genotype and clinical outcome prediction in the era of precision medicine. The fast dispersal of this new methodology has benefited from the existing advances of the core technologies involve...

Full description

Bibliographic Details
Main Author: Binsheng Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.633176/full
id doaj-e5fd6ab497da462ebd775e18b0d15655
record_format Article
spelling doaj-e5fd6ab497da462ebd775e18b0d156552021-03-29T06:23:59ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-03-011110.3389/fonc.2021.633176633176Understanding Sources of Variation to Improve the Reproducibility of RadiomicsBinsheng ZhaoRadiomics is the method of choice for investigating the association between cancer imaging phenotype, cancer genotype and clinical outcome prediction in the era of precision medicine. The fast dispersal of this new methodology has benefited from the existing advances of the core technologies involved in radiomics workflow: image acquisition, tumor segmentation, feature extraction and machine learning. However, despite the rapidly increasing body of publications, there is no real clinical use of a developed radiomics signature so far. Reasons are multifaceted. One of the major challenges is the lack of reproducibility and generalizability of the reported radiomics signatures (features and models). Sources of variation exist in each step of the workflow; some are controllable or can be controlled to certain degrees, while others are uncontrollable or even unknown. Insufficient transparency in reporting radiomics studies further prevents translation of the developed radiomics signatures from the bench to the bedside. This review article first addresses sources of variation, which is illustrated using demonstrative examples. Then, it reviews a number of published studies and progresses made to date in the investigation and improvement of feature reproducibility and model performance. Lastly, it discusses potential strategies and practical considerations to reduce feature variability and improve the quality of radiomics study. This review focuses on CT image acquisition, tumor segmentation, quantitative feature extraction, and the disease of lung cancer.https://www.frontiersin.org/articles/10.3389/fonc.2021.633176/fullradiomicslung cancerreproducibilityvariabilityCT acquisitiontumor segmentation
collection DOAJ
language English
format Article
sources DOAJ
author Binsheng Zhao
spellingShingle Binsheng Zhao
Understanding Sources of Variation to Improve the Reproducibility of Radiomics
Frontiers in Oncology
radiomics
lung cancer
reproducibility
variability
CT acquisition
tumor segmentation
author_facet Binsheng Zhao
author_sort Binsheng Zhao
title Understanding Sources of Variation to Improve the Reproducibility of Radiomics
title_short Understanding Sources of Variation to Improve the Reproducibility of Radiomics
title_full Understanding Sources of Variation to Improve the Reproducibility of Radiomics
title_fullStr Understanding Sources of Variation to Improve the Reproducibility of Radiomics
title_full_unstemmed Understanding Sources of Variation to Improve the Reproducibility of Radiomics
title_sort understanding sources of variation to improve the reproducibility of radiomics
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2021-03-01
description Radiomics is the method of choice for investigating the association between cancer imaging phenotype, cancer genotype and clinical outcome prediction in the era of precision medicine. The fast dispersal of this new methodology has benefited from the existing advances of the core technologies involved in radiomics workflow: image acquisition, tumor segmentation, feature extraction and machine learning. However, despite the rapidly increasing body of publications, there is no real clinical use of a developed radiomics signature so far. Reasons are multifaceted. One of the major challenges is the lack of reproducibility and generalizability of the reported radiomics signatures (features and models). Sources of variation exist in each step of the workflow; some are controllable or can be controlled to certain degrees, while others are uncontrollable or even unknown. Insufficient transparency in reporting radiomics studies further prevents translation of the developed radiomics signatures from the bench to the bedside. This review article first addresses sources of variation, which is illustrated using demonstrative examples. Then, it reviews a number of published studies and progresses made to date in the investigation and improvement of feature reproducibility and model performance. Lastly, it discusses potential strategies and practical considerations to reduce feature variability and improve the quality of radiomics study. This review focuses on CT image acquisition, tumor segmentation, quantitative feature extraction, and the disease of lung cancer.
topic radiomics
lung cancer
reproducibility
variability
CT acquisition
tumor segmentation
url https://www.frontiersin.org/articles/10.3389/fonc.2021.633176/full
work_keys_str_mv AT binshengzhao understandingsourcesofvariationtoimprovethereproducibilityofradiomics
_version_ 1724199126027993088